Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ovarian Neoplasms

Free Subscription 03.08.2026 1 Br J Cancer 1 Clin Cancer Res 1 J Natl Cancer Inst 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Cancer

1. KANG MS, Katuwal NB, Ghosh M, Hong SD, et al
   JPI-547, a novel dual inhibitor of PARP1/2 and tankyrase is more effective than first-generation PARP inhibitors in preclinical BRCA1/2-mutated cancer models.
   Br J Cancer. 2026;135:503-517.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

2. HARANO K, Nakao T, Nishio S, Katsuda T, et al
   Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.
   Clin Cancer Res. 2026 Jul 30. doi: 10.1158/1078-0432.CCR-25-4887.
   PubMed         Abstract available
   
   

   
   J Natl Cancer Inst

3. BAHRAMI F, McLeod J, Pearce CL, Kushi LH, et al
   Effectiveness of opportunistic bilateral salpingectomy in preventing epithelial ovarian cancer: a population-based study.
   J Natl Cancer Inst. 2026 Jul 29:djag251. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   PLoS One

4. 
   Editorial Note: NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin.
   PLoS One. 2026;21:e0354761.
   PubMed        
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum